>

Emily Waltenbaugh

  • Vanderbilt University

    Hartert conducts study on respiratory syncytial virus in asthma development

    When a team of Vanderbilt scientists in the Division of Allergy, Pulmonary and Critical Care Medicine received a $4.5 million grant to study the role of respiratory syncytial virus (RSV) in asthma development, they had no idea that a global pandemic would not only interfere with and delay their initial… Read More

    Aug. 2, 2022

  • Vanderbilt University

    Honors and Awards – June 2022

    Allie Lake (G2) was selected to give a talk at the World Congress of Psychiatric Genetics conference in Florence, Italy!   Ansley Kunnath (G2) was awarded a grant from VICTR for a clinical trial that she’s leading! Stephanie… Read More

    Jul. 29, 2022

  • Vanderbilt University

    MSTPublications: July 2022

    Allele-specific activation, enzyme kinetics, and inhibitor sensitivities of EGFR exon 19 deletion mutations in lung cancer. Brown BP, Zhang YK, Kim S, Finneran P, Yan Y, Du Z, Kim J, Hartzler AL, LeNoue-Newton ML, Smith AW, Meiler J, Lovly CM. Read More

    Jul. 29, 2022

  • Vanderbilt University

    Cooper investigates trauma surgery patient outcomes and physician unprofessionalism in new study

    William Cooper, MD, MPH, and colleagues previously reported that patients of surgeons with higher numbers of reports from co-workers about unprofessional behavior are more likely to experience complications, and that patient and family reports about rude and disrespectful behavior can identify surgeons with higher rates of surgical site infections and… Read More

    Jul. 28, 2022

  • Vanderbilt University

    Heimburger to co-lead Vanderbilt-Zambia Cancer Research Training Program

    Vanderbilt University Medical Center and the University of Zambia (UNZA) are partnering on a program to develop a cadre of researchers and educators to lead cancer epidemiology research and training in Zambia and to encourage U.S.-based researchers to engage in cancer research in low- and middle-income countries. In partnership with… Read More

    Jul. 27, 2022

  • Vanderbilt University

    Self investigates effects of convalescent plasma transfusion on improving clinical outcomes in COVID patients

    Convalescent plasma, widely given to severely ill patients hospitalized with COVID-19 during the pandemic, does not improve their ability to survive or recover, according to a national clinical trial led by Vanderbilt University Medical Center and published in the journal CHEST. The multicenter blinded, randomized placebo-controlled, Passive Immunity Trial for our… Read More

    Jul. 26, 2022

  • Vanderbilt University

    COVID vaccinations during pregnancy reduce likelihood for viral infection in newborns, says Halasa

    Infants younger than 6 months were better protected from COVID-19 complications when mothers received two doses of the vaccine while pregnant, according to researchers. Mothers who received COVID-19 vaccinations during pregnancy reduced the risk of hospitalization for this age group by 80% during the delta wave and nearly 40% during… Read More

    Jul. 25, 2022

  • Stephen Raffanti, MD, MPH

    Celebrating a legacy: Raffanti discusses journey into medicine and combatting AIDS

    On June 29 Stephen Raffanti, MD, MPH, hung up his scrubs at the Vanderbilt Comprehensive Care Clinic for the last time. It was a bittersweet moment for the man who helped lead Nashville out of the darkest days of the AIDS epidemic 30 years ago. “I’ll miss you,” Raffanti told… Read More

    Jul. 19, 2022

  • A woman stands behind a rail. She's wearing a white coat.

    Meet a Medical Scholar: Maddy Ball

    M3 Maddy Ball traveled to Barcelona, Spain, for a year-long research project By: Lexie Little Maddy Ball is no stranger to travel. Maddy Ball hikes all over the world. Her favorite trails in Tennessee include Fiery Gizzard and nearby Beaman Park. A native of Mill Valley, California, just outside of… Read More

    Jul. 11, 2022

  • Vanderbilt University

    Horn leads study on opioid use after childbirth and associated death risks

    In a new study led by Vanderbilt University Medical Center researchers, women who filled two or more prescriptions for opioids after childbirth faced a 46% greater risk of death than women who did not. The study, led by the late Arlyn Horn, PharmD, MPH and Margaret Adgent, MSPH, PhD, research… Read More

    Jul. 6, 2022